These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3779525)

  • 1. Recovery of Mycobacterium avium after treatment with chemical decontaminants.
    Jaramillo VL; McCarthy CM
    Can J Microbiol; 1986 Sep; 32(9):728-32. PubMed ID: 3779525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium avium infections of Acanthamoeba strains: host strain variability, grazing-acquired infections, and altered dynamics of inactivation with monochloramine.
    Berry D; Horn M; Xi C; Raskin L
    Appl Environ Microbiol; 2010 Oct; 76(19):6685-8. PubMed ID: 20709834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of commercial tuberculocidal products: normalization].
    Carrera JV
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):122; author reply 122-3. PubMed ID: 18341929
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of Mycobacterium avium with monochloramine.
    Luh J; Tong N; Raskin L; Mariñas BJ
    Environ Sci Technol; 2008 Nov; 42(21):8051-6. PubMed ID: 19031901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery and survival of nontuberculous mycobacteria under various growth and decontamination conditions.
    Brooks RW; George KL; Parker BC; Falkinham JO; Gruff H
    Can J Microbiol; 1984 Sep; 30(9):1112-7. PubMed ID: 6509392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Mycobacterium avium with free chlorine.
    Luh J; Mariñas BJ
    Environ Sci Technol; 2007 Jul; 41(14):5096-102. PubMed ID: 17711229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A luciferase-based method for assessing chlorine-susceptibility of Mycobacterium avium.
    Cowan HE; Falkinham JO
    J Microbiol Methods; 2001 Sep; 46(3):209-15. PubMed ID: 11438185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages.
    Maisetta G; Batoni G; Pardini M; Boschi A; Bottai D; Esin S; Campa M; Senesi S
    Antimicrob Agents Chemother; 2001 Jan; 45(1):356-8. PubMed ID: 11120998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of Mycobacterium avium with chlorine dioxide.
    Vicuña-Reyes JP; Luh J; Mariñas BJ
    Water Res; 2008 Mar; 42(6-7):1531-8. PubMed ID: 18023466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disinfection efficiency of peracetic acid, alone and in combination with hypochlorite, against Mycobacterium avium in drinking water].
    Schiavano GF; Sisti M; De Santi M; Brandi G
    Ann Ig; 2006; 18(5):375-82. PubMed ID: 17089953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of acid resistance in Listeria monocytogenes and Salmonella enterica strains before and after exposure to poultry decontaminants. Role of the glutamate decarboxylase (GAD) system.
    Alonso-Hernando A; Alonso-Calleja C; Capita R
    Food Microbiol; 2009 Dec; 26(8):905-9. PubMed ID: 19835779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.
    McCarthy CM
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):450-3. PubMed ID: 7224357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.
    Tsukamura M
    Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on colistin (polymyxin E)-induced cell leakage in mycobacteria: Mg++ efflux in Mycobacterium avium and its effects on drug-susceptibility.
    Rastogi N; Potar MC; Henrotte JG; Franck G; David HL
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):251-8. PubMed ID: 3394452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-microbial activity of electrolysed oxidizing water against microorganisms relevant in veterinary medicine.
    Fenner DC; Bürge B; Kayser HP; Wittenbrink MM
    J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):133-7. PubMed ID: 16629725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.
    Deshpande D; Srivastava S; Meek C; Leff R; Gumbo T
    Antimicrob Agents Chemother; 2010 May; 54(5):1728-33. PubMed ID: 20231389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility.
    Heifets LB; Iseman MD
    N Engl J Med; 1990 Aug; 323(6):419-20. PubMed ID: 2370896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.